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 Abstract 
To clarify the causal role of age at menarche in depressive symptoms we conducted a Mendelian 
randomization study using a large Southern Chinese cohort (n=12,233). A genetic allele score 
was derived using stepwise regression with cross validation. Older age at menarche was not 
associated with geriatric depression scale score. Our findings suggest that higher rates of 
depression in women are likely attributable to other factors which require investigation. 
Keywords: China; Epidemiology 
  
DNA: Deoxyribonucleic acid; GBCS: Guangzhou Biobank Cohort Study; GDS: Geriatric Depression 
Scale; GWAS: Genome wide association study; RCTs: Randomized controlled trials; SEP: 
Socioeconomic position; SNP: Single nucleotide polymorphism 
 
1. Introduction 
Women have higher risk of depression than men (Riecher-Rossler, 2017), possibly due to 
differences in social roles and norms, vulnerability to adverse life events, or estrogen (Kuehner, 
2017; Piccinelli and Wilkinson, 2000). Observations concerning the relation of age at menarche, 
a proxy for estrogen exposure (on the basis of similar associations with breast and endometrial 
cancer risk (Collaborative Group on Hormonal Factors in Breast Cancer, 2012; Day et al., 2017; 
Rossouw et al., 2002)), with depression are mixed (Herva et al., 2004; Joinson et al., 2013; Wang 
et al., 2016). These discrepancies may be due to short-term effects, contextually specific effects, 
or confounding by childhood adiposity and lower socioeconomic position (SEP). Specifically, 
obesity increases leptin whereas lower SEP may provide cues for inducing earlier initiation of 
reproduction, all of which may lead to earlier age at menarche (Al-Sahab et al., 2010; Villamor 
and Jansen, 2016). Randomized controlled trials (RCTs) of age at menarche are impossible. 
Trials of one mediating pathway, i.e., estrogen, are inconclusive (Demetrio et al., 2011; Gleason 
et al., 2015). To address this question, Mendelian randomization offers a way forward as this 
design uses genetic variants associated with age at menarche randomly allocated at conception 
and hence is less susceptible to confounding by childhood adiposity or SEP (Lawlor et al., 2008). 
The most recent Mendelian randomization study only addressed the effect of age at menarche on 
depressive symptoms in adolescence (Sequeira et al., 2017), uncertainty exists as to whether age 
at menarche has long-term effects on adult depression. To clarify we conducted a Mendelian 
randomization study of age at menarche on depressive symptoms among older Chinese women. 
Given later age at menarche is associated with taller height (Onland-Moret et al., 2005), we 
considered height as a positive control outcome (Lipsitch et al., 2010). 
 2. Methods  
The Guangzhou Biobank Cohort Study (GBCS) is an ongoing collaboration of Guangzhou 
Number 12 Hospital, the Universities of Hong Kong and Birmingham, UK, which has been 
described in detail elsewhere (Jiang et al., 2006). Age at menarche was recorded in years (as per 
the Gregorian calendar and related interpretation of age), rounded to the nearest year (e.g., 13 
years represents the onset of menarche from 12 years 6 months to 13 years 5 months) (Heys et al., 
2007). Depressive symptoms were assessed by the Chinese version of the 15-item Geriatric 
Depression Scale (GDS) which has been used before in Chinese (Lin et al., 2014).   
 
The Guangzhou Medical Ethics Committee of the Chinese Medical Association approved GBCS, 
including the use of genetic data. All participants gave written, informed consent prior to 
participation.  
 
2.1 Deoxyribonucleic acid (DNA) extraction and single nucleotide polymorphism (SNP) analysis 
DNA was extracted at Guangzhou Number 12 Hospital from buffy coat previously stored at -
80°C using a magnetic bead extraction procedure (MagPure Blood DNA Mini Kit). DNA 
concentrations were checked by Nanodrop (Thermoscientific, USA). For DNA concentrations 
<15 ng/µl, a silica-based column method was also used to re-extract DNA manually (HiPure 
Blood DNA Mini Kit). Almost all (92%) of the DNA samples passed quality control before 
genotyping. Genotyping was performed using the MassARRAY Sequenom platform (San Diego, 
 CA, USA) at the Beijing Genomics Institute, Beijing. The average genotyping call rate of these 
SNPs was 98%. 
 
2.2 Genetic Instruments 
A priori, we selected 12 SNPs previously reported strongly associated with age at menarche 
which vary in East Asian populations, including rs13357391, rs1859345, rs2348186 and 
rs7701979 (SPOCK), rs17268785 (CCDC85A), rs2090409, rs4452860, rs7861820 (9q31.2 
region) and rs314276, rs369065, rs4946651, rs7759938 (LIN28B) (Dvornyk and Waqar-ul-Haq, 
2012), because no genome wide association study (GWAS) of age at menarche in East Asians 
was available when we conducted the study. Correlations between SNPs are from SNP 
Annotation and Proxy Search (http://www.broad.mit.edu/mpg/snap/ldsearchpw.php) using the 
HapMap (release #22, JPT+CHB) reference. For SNPs in linkage disequilibrium (r2≥0.8), the 
SNP with a larger p-value was discarded. rs13357391 and rs7701979 were discarded because of 
correlation with rs1859345 and rs7759938 because of correlation with rs4946651. The remaining 
9 SNPs were considered for inclusion in a genetic allele score to reduce the likelihood of weak 
instrument bias (Lawlor et al., 2008). The same approach has been used in our previous study 
(Au Yeung et al., 2017). 
 
The outcome was GDS score for depressive symptoms.  
 
2.3 Statistical analysis 
 We tested Hardy-Weinberg equilibrium at the SNP locus on a contingency table of observed-
versus-predicted frequencies with an exact test. SNPs which deviated from equilibrium were 
discarded. We used stepwise linear regression to find a parsimonious set of SNPs which 
predicted age at menarche, with significance set at 0.20, as previously (Zhao et al., 2014). To 
reduce the likelihood of false positive in the selection of SNPs based on one sample, we used 10-
fold cross validation (k=10) (Schonlau, 2005). The F-statistic for age at menarche on genetic 
score was obtained, a value ≥10 indicates weak instrument bias is unlikely (Lawlor et al., 2008). 
We used analysis of variance to assess whether genetically estimated age at menarche was 
associated with potential confounders. We conducted instrumental variable analysis using 2 stage 
least squares, with the genetic score as the instrument, to assess the associations of age at 
menarche with GDS score and height. For comparison, we also present estimates from 
multivariable linear regression, adjusting for education, and recruitment phase (model 1) and 
additionally adjusting for age, smoking, alcohol use, physical activity, and job type (model 2). 
 
All statistical analyses were conducted using Stata 13.1 (StataCorp LP, College Station, Texas, 
USA). 
 
3. Results 
Among 22,054 women in GBCS, 12,679 had at least one SNP after excluding correlated SNPs. 
rs369065 and rs2348186 deviated from Hardy Weinberg equilibrium (p=0.04 and p<0.001 
respectively) and were discarded. rs314276 was discarded as only 8,068 women (63%) had this 
SNP. From the stepwise regression with cross validation, rs17268785 (CCDC85A), rs1859345 
 (SPOCK), rs2090409 (9q31.2 region), rs4452860 (9q31.2 region) and rs4946651 (LIN28B) 
predicted age at menarche with a p value of ≤0.20 in at least 5 of the datasets and were used in 
the genetic allele score (F-statistic 19.9, n=12,290). The mean age at menarche in this cohort was 
14.95 years with standard deviation 2.0. 
 
Genetically estimated age at menarche was not associated with age, smoking, physical activity, 
education, or job type, but was associated with alcohol use, with a very small difference, as 
shown in our previous study (Au Yeung et al., 2017). Observationally older age at menarche was 
associated with higher GDS score (Table 1) in model 1 but not in model 2. Using Mendelian 
randomization, older age at menarche was not clearly associated with GDS score, but was 
associated with taller height. Repeating the analyses without rs2090409 and rs4452860, which 
did not replicate well in the cross validation, showed directionally similar results although 
estimates had wider confidence intervals. Repeating the analysis excluding the samples with re-
extraction (10%) did not change the conclusion from the Mendelian randomization analysis (data 
not shown). 
 
4. Discussion 
This Mendelian randomization study showed that age at menarche was not clearly associated 
with depressive symptoms although we cannot rule out such an association. Consistent with 
these findings, estrogen is not clearly associated with depressive symptoms in RCTs (Demetrio 
et al., 2011; Gleason et al., 2015), or Mendelian randomization study (Au Yeung et al., 2016). As 
such, other means to reduce the gender inequalities in mental health are required.  
  
We used Mendelian randomization in a large sample, but limitations exist. First, Mendelian 
randomization studies have stringent assumptions. The SNPs were selected a priori from a 
previous GWAS of age at menarche, and are related to other phenotypes, such as diabetes 
(CCDC85A), proteoglycan (SPOCL) and cancer (9q31.2 and LIN28B) but these conditions are 
not known to be directly associated with depressive symptoms. In addition, we could not include 
all SNPs from previous GWAS (Perry et al., 2014). Second, age at menarche was based on recall 
although high correlations between recalled and actual age at menarche have been found (Must 
et al., 2002). Third, Mendelian randomization studies can be underpowered although our study 
showed the expected relation with height. Finally, not all SNPs were available for all GBCS 
participants. However, our estimates would only be biased if genotype determined follow up, 
which was unlikely. 
 
Our study does not provide strong evidence that age at menarche, possibly an indication of 
estrogen exposure, contributes to higher rates of depression in women. The difference is likely to 
be attributable to other factors, such as structural gender inequities, which require investigation 
in further studies. 
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 Table 1: Association of age at menarche (years) with Geriatric Depression Scale (GDS) score in 12,233 Southern Chinese older 
women in the Guangzhou Biobank Cohort Study using Mendelian randomization and multivariable regression analysis 
 
Mendelian randomization a,bMultivariable linear regression  
 
All SNPs  
(F-statistics: 19.9) 
Excluding rs2090409 and rs4452860  
(F-statistics: 16.9) Model 1 Model 2 
  n β 95% CI n β 95% CI n β 95% CI n β 95% CI 
GDS 12,233 -0.43 -0.93 to 0.06 12,362 -0.43 -0.96 to 0.09 12,643 0.023 0.004 to 0.04 12,484 0.017 -0.002 to 0.04 
 
            
Height (cm) 12,279 1.36 0.038 to 2.69 12,410 1.39 -0.03 to 2.82 12,692 0.13 0.08 to 0.17 12,533 0.19 0.14 to 0.24 
aModel 1 adjusted for education and recruitment phase; Model 2 additionally adjusted for age, smoking, alcohol use, physical activity, and job type 
 
 
 
 
 
